Michael Mezher - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Michael Mezher's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Michael Mezher
Verified
Managing Editor, Regulatory Focus
Long Beach
Beats
Politics , Europe , Culture , History , Germany
Anything that isn't sport.
Content
By Michael Mezher Verified, Ferdous Al-Faruque, Joanne S. Eglovitch| Friends of Cancer Research@ Michael Mezher, Ferdous Al-Faruque, and Joanne S. Eglovitch Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, we learned that FDA has filled two leadership roles at the agency, and that it will host an upcoming patient-focused drug development (PFDD) meeting focused on long COVID.
By Michael Mezher Verified| Regulatory Affairs Professionals Society@ This Week at FDA: FDA approves first FMT product, upcoming mpox guidance, and more This Week at FDA | 02 December 2022 | By Michael Mezher • Ferdous Al-Faruque Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web.
By Michael Mezher Verified, Ferdous Al-Faruque, Joanne S. Eglovitch| Friends of Cancer Research@ Michael Mezher, Ferdous Al-Faruque, and Joanne S. Eglovitch Welcome to another installment of This Week at FDA, your weekly source for updates – big and small – on FDA, drug and medical device regulation, and what we’re reading from around the web. This week, we learned that FDA has filled two leadership roles at the agency, and that it will host an upcoming patient-focused drug development (PFDD) meeting focused on long COVID.
Company Info
Regulatory Focus